Menendez, Javier A
Mayo Clinic
Metabolism and Cancer Group, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology, 17005 Girona, Spain.
Citations 18
Fatty acid synthase (FASN) as a therapeutic target in breast cancer
Menéndez, Javier A. , Lupu, Ruth , Menendez, Javier A
Expert Opinion on Therapeutic Targets | September 18, 2017 | Volume: 21 | Issue: 11 | Pages: 1001-1016
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancer-initiating cells
Cuyàs, Elisabet , Corominas-Faja, Bruna, Martín, María Muñoz‐San , Martı́n-Castillo, Begoña , Lupu, Ruth , Brunet, Joan , Bosch‐Barrera, Joaquim , Menéndez, Javier A. , Brunet, Joan , Bosch-Barrera, Joaquim , Menendez, Javier A , Cuyàs, Elisabet
Oncotarget | March 25, 2017 | Volume: 8 | Issue: 21 | Pages: 35019-35032
The metastasis inducer CCN1 (CYR61) activates the fatty acid synthase (FASN)-driven lipogenic phenotype in breast cancer cells
Menéndez, Javier A. , Vellón, Luciano , Espinoza, Ingrid, Lupu, Ruth , Espinoza, Ingrid , Menendez, Javier A
Oncoscience | August 29, 2016 | Volume: 3 | Issue: 7-8 | Pages: 242-257
Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based “starvation” strategies in BRCA1 carriers
Cuyàs, Elisabet , Fernández‐Arroyo, Salvador , Alarcón, Tomás , Lupu, Ruth , Menéndez, Javier A. , Joven, Jorge , Menendez, Javier A , Cuyàs, Elisabet , Fernández-Arroyo, Salvador
Oncotarget | May 31, 2016 | Volume: 7 | Issue: 33 | Pages: 52974-52992
Suppression of endogenous lipogenesis induces reversion of the malignant phenotype and normalized differentiation in breast cancer
González-Guerrico, Anatilde M., Espinoza, Ingrid , Schroeder, Barbara, Park, Cheol Hong, KVP, Chandra Mohan, Khurana, Ashwani, Corominas-Faja, Bruna, Cuyàs, Elisabet , Alarcón, Tomás , Kleer, Celina G. , Menéndez, Javier A. , Lupu, Ruth , Menendez, Javier A , Cuyàs, Elisabet
Oncotarget | May 19, 2016 | Volume: 7 | Issue: 44 | Pages: 71151-71168
Heregulin, a new regulator of telomere length in human cells
Menéndez, Javier A. , Campisi, Judith , Lupu, Ruth , Rubio, Miguel A. , Menendez, Javier A
Oncotarget | September 29, 2015 | Volume: 6 | Issue: 37 | Pages: 39422-39436
Heregulin, a new interactor of the telosome/shelterin complex in human telomeres
Menéndez, Javier A. , Benboudjema, Louisa, Vellón, Luciano , Espinoza, Ingrid, Campisi, Judith , Lupu, Ruth , Rubio, Miguel A., Espinoza, Ingrid , Menendez, Javier A
Oncotarget | September 29, 2015 | Volume: 6 | Issue: 37 | Pages: 39408-39421
CCN1 promotes vascular endothelial growth factor secretion through αvβ3 integrin receptors in breast cancer
Espinoza, Ingrid, Menéndez, Javier A. , KVP, Chandra Mohan, Lupu, Ruth , Espinoza, Ingrid , Menendez, Javier A
Journal of Cell Communication and Signaling | December 11, 2013 | Volume: 8 | Issue: 1 | Pages: 23-27